Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes—Good or excellent?
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.2893
Abstract: Atrial fibrillation (AF) is associated with an increased risk of stroke, systemic embolism, and death. In the last decade, novel oral anticoagulants (NOACs) have emerged and are nowadays a key player in the anticoagulant armamentarium… read more here.
Keywords: atrial fibrillation; oral anticoagulants; anticoagulants noacs; novel oral ... See more keywords